AstraZeneca Faces Investigation by PRC, Shares Plummet

AstraZeneca, the pharmaceutical giant, is under investigation by the People's Republic of China (PRC) due to allegations of fraud and corruption. This news has caused a sharp decline in the company's shares. The PRC probe has raised serious concerns among investors, leading to a drop in confidence in AstraZeneca's operations. The allegations have also prompted skepticism regarding the company's future prospects, especially in the Chinese market. With this development, it is advisable to seek professional advice from the experts at Stocks Prognosis to understand the forecasted movement of AstraZeneca's shares.